CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GC Cell Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GC Cell Corp
107, Ihyeon-ro 30beon-gil, Giheung-gu
Phone: +82 312609300p:+82 312609300 YONGIN, 16924  South Korea Ticker: 144510144510
This is a Subsidiary, click here for the Parent Company
Business Summary
GC Cell Corp formerly Green Cross Lab Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company operates its business through four segments. The Specimen Testing Service segment provides sample testing services, clinical trial services, and veterinary testing services. The Cell Therapy segment is engaged in cell culture and technology transfer business. The Cord Blood Storage segment is engaged in the cord blood storage business. The Other Business segment is engaged in bio-logistics business and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
8071 Medical laboratories
8099 Health and allied services, not elsewhere classified
2836 Biological products, except diagnostic substances
4213 Trucking, except local

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jong EunPark 56 3/28/2023 3/28/2023
Vice Chairman Deuk JuLee 63 1/1/2021 1/1/2021
Managing Director Yu GyeongHwang 56
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 427 (As of 6/30/2019)
Outstanding Shares: 15,027,141 (As of 6/30/2024)
Shareholders: 45,720
Stock Exchange: KDQ
Fax Number: +82 312609232


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024